Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 18/20 | 0.72 |
| ▸ | FNTB | P49356 | 16/20 | 0.72 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6470236 | 0.90 | FNTA (0.88) | FNTAFNTBPGGT1B | |
| SCHEMBL1759375 | 0.90 | FNTA (0.88) | FNTAFNTBPGGT1B | |
| SCHEMBL1531788 | 0.89 | FNTA (0.85) | FNTAFNTBPGGT1B | |
| SCHEMBL335747 | 0.89 | FNTA (0.85) | FNTAFNTBPGGT1B | |
| SCHEMBL29414931 | 0.87 | FNTA (0.78) | FNTAFNTBPGGT1B | |
| SCHEMBL14740623 | 0.87 | FNTA (0.65) | FNTAFNTBPGGT1B | |
| SCHEMBL18486481 | 0.85 | FNTA (0.94) | FNTAFNTBPGGT1B | |
| SCHEMBL18486480 | 0.85 | FNTA (0.94) | FNTAFNTBPGGT1B | |
| SCHEMBL8386587 | 0.85 | FNTA (0.78) | FNTAFNTBPGGT1B | |
| SCHEMBL18486684 | 0.85 | FNTA (0.94) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040121985-A1 | Novel prenyl transferase inhibitors | GIBBS RICHARD A | 2004-06-24 | — | — | US | disclosed |
| US-6586461-B1 | Geranylgeranyl transferase inhibitors comprising farnesol and geranylgeraniol analogs, used as anticarcinogenic agents and for prevention of restenosis | WAYNE STATE UNIVERSITY | 2003-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040121985-A1 | Novel prenyl transferase inhibitors | FNTA, FNTB, GGPS1 | FNTA 1/4885FNTB 2/4885PGGT1B 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.